Patient information leaflets about cancer trials are too complicated, finds study. BMJ. 2012 Mar 27;344:e2356 46 Fiva JH, Haegeland T, Ronning M, Syse A. Access to treatment and ...
Patients completed a previsit survey to assess importance of specific information when making a preventive screening decision. Visits were audio recorded to assess the content of screening discussions. Most patients rated test accuracy (85%), testing alternatives (83%), the pros and cons of testing...
2025年欧洲肺癌大会(ELCC)将于当地时间3月26日-29日在法国巴黎召开,作为肺癌领域备受关注的重要国际学术会议之一,ELCC汇聚了全球肺癌诊疗的最新技术及研究成果。日前,ELCC官网在线公布了摘要标题(LBA暂未公布),本文整理了优选论文专场(Proffered Paper session)和迷你口头报告专场(Mini oral session)的研究,快来看看吧!
unpaired or paired 2-tailed student’s t-test was used to test the significance of differences between the two groups. Two-way analysis of variance (ANOVA) was used to compare the effects of different factors
Available online: https://www.Cancer.Gov/Publications/Dictionaries/Cancer-Terms/Def/Tumor-Marker-Test (accessed on 22 February 2022). Schienda, J.; Church, A.J.; Corson, L.B.; Decker, B.; Clinton, C.M.; Manning, D.K.; Imamovic-Tuco, A.; Reidy, D.; Strand, G.R.; Applebaum,...
[137] developed multiplex drop-off droplet digital PCR (ddPCR) assays, targeting four BC microsatellites and showing that MSI can be an actionable marker for immunotherapy [137]. BC diagnosis using predefined microsatellite panels is still a challenge, unlike most tumor types that need a limited ...
18 The National Cancer Institute provides strategies for reducing cervical cancer mortality in its report “Excess Cervical Cancer Mortality: A Marker for Low Access to Health Care in Poor Communities.”19 Other Considerations Implementation Participation in regular screening has a far greater effect on...
OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J. Pathol. 211, 1–9 (2007). This is a comprehensive review on the discovery and application of diagnostic biomarkers. CAS PubMed Google Scholar Ulbright, T. M., Tickoo, S. K., Berney, D. M. ...
Second, for patients with positive tumour markers before surgery, post-operative tumour marker response and the number of positive tumour markers after surgery with traditional clinicopathological variables was included in the univariable analyses. The variables associated with survival with P < 0.05 ...
This is of particular relevance as non-marker expressing populations might acquire a CSC phenotype and functionality at another moment during tumor growth. Another limitation of these assays is the disruption of the original tumor architecture resulting in an artificial analysis of stem cell properties,...